Letter to the Editor
- Page Path
-
- HOME
- ARTICLE CATEGORY
- Letter to the Editor
- Letter to the Editor
-
Antitoxin treatment for liver abscess caused by
Clostridium perfringens - Toru Hifumi, Yuichi Koido, Motohide Takahashi, Akihiko Yamamoto
- Clin Mol Hepatol. 2013;19(1):97-98. Published online March 25, 2013
-
View: 5956 Download: 71 Web of Science: 3 Crossref: 6
- Changing from NAFLD to MASLD: Cumulative incidence of gallstones between patients with NAFLD and those with MASLD in Asia
- Shuhei Fukunaga, Tomoyuki Nakane, Michita Mukasa, Hidetoshi Takedatsu, Takumi Kawaguchi
- Received April 7, 2024 Accepted May 10, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0233 [Accepted]
-
View: 381 Download: 30 Crossref: 1
- Dipeptidyl peptidase-4 inhibitors are associated with improved survival of patients with diabetes mellitus and hepatocellular carcinoma receiving immunotherapy
- Dorothy Cheuk-Yan Yiu, Huapeng Lin, Vincent Wai-Sun Wong, Grace Lai-Hung Wong, Ken Liu, Terry Cheuk-Fung Yip
- Received April 18, 2024 Accepted July 4, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0280 [Accepted]
-
View: 147 Download: 15
- Equivalent Prevalence and Progression of Chronic Kidney Disease in NAFLD and MASLD
- Hiroyuki Suzuki, Tsubasa Tsutsumi, Machiko Kawaguchi, Keisuke Amano, Takumi Kawaguchi
- Received April 15, 2024 Accepted May 20, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0264 [Accepted]
-
View: 431 Download: 50
- MAFLD-related hepatocellular carcinoma in China: An increasing problem
- Xiangyu Wu, Wenjing Ni, Qianqian Chen, Junping Shi, Jie Li
- Received May 22, 2024 Accepted June 17, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0386 [Accepted]
-
View: 388 Download: 26
- Metabolic-associated fatty liver disease is less effective in predicting mortality than non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease
- Yixuan Zhu, Yee Hui Yeo, Xiaoyan Ma, Wenjing Ni, Junping Shi, Jie Li
- Received June 3, 2024 Accepted July 3, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0417 [Accepted]
-
View: 186 Download: 19
-
Clinical and
Molecular
HepatologyPrint ISSN: 2287-2728
Online ISSN: 2287-285X
-
-
- Immunopathogenesis of liver fibrosis in steatotic liver disease
- Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
- Recent updates on pharmacologic therapy in non-alcoholic fatty liver disease
- The role of the hepatic autonomic nervous system
- HBeAg-positive grey-zone patients: Treatment beyond guideline recommendations?
- Systemic therapy in advanced hepatocellular carcinoma
- Epidemiology and updated management for autoimmune liver disease
- Microbiome and metabolomics in alcoholic liver disease
- Personalized medicine in nonalcoholic fatty liver disease
- Acute on chronic liver failure in cirrhosis
- Current status and outcome of liver transplantation in South Korea
- History and future of hepatitis B virus control in South Korea
- Hepatocellular carcinoma statistics in South Korea
Impact Factor14.0First decision
09 Days
Publication after acceptance
03 Days
*Last 12 months
- MOST VIEWED (Last 6 months)
- MOST CITED (2022-2024)
|
|||||||
